News & Resources

Getting neuroimaging right — How to succeed in neurodegenerative clinical trials

Amyloid PET centiloid: impact of calibration and processing steps

Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease

• Category: Huntington's Disease, CHDI, HD-IH
• Date: 21/09/2022

Call to Action – New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease

Published on: September 21, 2022 View the full News here; Call to Action – New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease About IXICO | Advanced Analytics | Intelligent Insights.

MDS 2022 Poster – An automated AI-based framework for putamen volume measurement in Multiple System Atrophy

EHDN Imaging Working Group Presentation on new HD-IH Consortium

• Category: Organisational News
• Date: 10/05/2022

Engagement in New Consortium in Huntington’s disease

Published on: 10th May 2022 View the full News here; Engagement in new consortium in Huntington’s disease About IXICO | Advanced Analytics | Intelligent Insights. IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's, Parkinson's, Alzheimer's disease and Multiple Sclerosis.

CHDI's 17th Annual Therapeutics Conference: The Future of Huntington's Research

CHDI’s 17th Annual Therapeutics Conference: Event ReviewBy Ronald Ramos (Senior Director, Business Development) and Kirsi Kinnunen (Senior Biomarker Scientist) CHDI’s 17th Annual HD Therapeutics Conference finally returned to a full, in-person event for the first time since 2020.